According to CRISPR Therapeutics's latest financial reports the company's current earnings (TTM) are -โน22.08 B. In 2023 the company made an earning of -โน12.65 B an increase over its 2022 earnings that were of -โน54.58 B.The earnings displayed on this page is the company's Pretax Income.